SEC Filing Summary: BioSig Technologies, Inc. (BSGM)
Business Context and Reporting Period
This Form 8-K was filed by BioSig Technologies, Inc. on March 10, 2021. The registrant is a Delaware corporation with principal executive offices in Westport, Connecticut, and its common stock trades on the NASDAQ Capital Market under the symbol BSGM. The filing serves as a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report regarding a specific event and does not contain financial statements or performance metrics.
Material Changes
No material changes to financial position or operations were reported in this filing. The document discloses a corporate event rather than a change in financial status.
Guidance, Outlook, and Management Commentary
On March 10, 2021, the Company issued a press release (Exhibit 99.1) announcing an invitation to attend the Oppenheimer 31st Annual Healthcare Conference on Thursday, March 18, 2021. The Company explicitly stated it undertakes no obligation to update, supplement, or amend the materials attached. The filing includes standard disclaimers that the information is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not intended to constitute a determination of materiality under Regulation FD.
Investor Verification Checklist
- Verify the date and agenda of the Oppenheimer 31st Annual Healthcare Conference.
- Review the attached press release (Exhibit 99.1) for specific details on the Company's presentation plans.
- Confirm the Company's current stock trading status on the NASDAQ Capital Market.
- Note that this filing contains no financial data; refer to the most recent 10-K or 10-Q for financial metrics.